An analysis of information from almost 1,700 U.S. hospitals found an increase in the use of clot-busting tissue plasminogen activator as a therapy for ischemic stroke, according to a study in the journal Circulation: Cardiovascular Quality and Outcomes. Among patients who were transported to hospitals swiftly and who did not have conditions that could increase the drug's risks, usage grew from 43% in 2003 to 77% in 2011. "We should be providing intravenous tPA to all eligible patients, which means that nearly a quarter of them are still missing that opportunity," researcher Dr. Lee Schwamm said.

Full Story:
HealthDay News

Related Summaries